Skip to Content

Factor V Activity Significantly Increased in Severe COVID-19

TUESDAY, Sept. 15, 2020 -- Factor V activity is significantly increased in patients with severe COVID-19, according to a study published online Aug. 24 in the American Journal of Hematology.

Jonathan A. Stefely, M.D., Ph.D., from Massachusetts General Hospital in Boston, and colleagues measured factor V, VIII, and X activity in a cohort of 102 consecutive inpatients with COVID-19; the cohort represented severe COVID-19, with high rates of ventilator use, line clots, deep vein thrombosis or pulmonary embolism (DVT/PE), and mortality (92, 47, 23, and 22 percent, respectively). In addition, contemporaneous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative controls and historical prepandemic controls were analyzed.

The researchers found that compared with contemporaneous controls, in COVID-19, factor V activity was significantly elevated (median, 150 versus 105 IU/dL). Significantly higher rates of DVT/PE were seen for patients with COVID-19 and factor V activity >150 IU/dL compared with those with factor V activity ≤150 IU/dL (33 versus 13 percent). Factor V activity was associated with SARS-CoV-2 viral load in a sex-dependent manner within the cohort. Subsequent reductions in factor V were associated with progression to disseminated intravascular coagulation and mortality.

"Our study reveals factor V perturbations as a previously unrecognized feature of severe COVID-19, adds a mechanistic candidate to ongoing investigations of COVID-19 coagulopathy with potential links to SARS-CoV-2 disease biology, and provides a foundation for future studies of COVID-19 coagulopathy diagnosis and biomarkers for guiding anticoagulation therapy in severe COVID-19," the authors write.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 19 to 23, 2021. This roundup...

Geographic Disparities Found in Cancer Diagnosis Stage, Mortality for AYAs

FRIDAY, July 23, 2021 -- For adolescents and young adults (AYAs) with cancer, living in rural counties and living farther from the reporting hospital are associated with...

Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices

FRIDAY, July 23, 2021 -- Racial- and ethnic-minority patients are underrepresented in the outpatient practices of many medical and surgical specialties, according to a research...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.